»Chikungunya: Valneva initiates a study on the homogeneity of the Phase 3 clinical batches of its single injection vaccine candidate MyPharma Editions

Posted on Monday, February 22, 2021 Valneva, a company specializing in vaccines against infectious diseases generating significant medical needs, announced that it has initiated a study to assess the homogeneity of Phase 3 clinical batches of its single injection vaccine candidate against chikungunya, VLA1553. This study will be carried out in parallel with the pivotal … Read more

study on the homogeneity of Phase 3 clinical batches of its candidate vaccine against chikungunya

Valneva SE, a company specializing in vaccines against infectious diseases generating significant medical needs, today announced that it has initiated a study to assess the homogeneity of Phase 3 clinical batches of its single injection vaccine candidate against chikungunya , VLA1553.This study will be carried out in parallel with the pivotal Phase 3 study already … Read more

New batches of Corona vaccines arrive in the Kingdom

The Saudi Minister of Health, Dr. Tawfiq Al-Rabiah, announced the arrival of new batches of the emerging coronavirus vaccine to the Kingdom of Saudi Arabia. Al-Rabiah said, in a tweet through his official account on the social networking platform, “Twitter,” today, Monday, February 15th, “New batches of the Corona vaccine arrived in the Kingdom after … Read more

Ranitidine Medication: Invima orders to recall all batches of injectable Ranitidine | Health

After, in the month of July, the Invima will order the recall of all Ranitidine tablet lots, after detecting Nitrosamines, a probably carcinogenic substance. The health authority extends this measure also to the same medicine, but in injectable solution. “He National Institute of Food and Drug Surveillance, Invima, informs that the preventive recall of all … Read more